Syndecan-2 and -4 expressed on activated primary human CD4+ lymphocytes can regulate T cell activation

Molecular Immunology

Volumn 45, Issue 10, 2008, Pages 2905-2919

  Teixé, Trini ^a   Nieto Blanco, Patricia ^a   Vilella, Ramon ^c   Engel, Pablo ^b   Reina, Manuel ^a   Espel, Enric ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

DNAse hypersensitivity; Heparan sulphate proteoglycans; p38 MAPK; T cell proliferation

Indexed keywords

CD3 ANTIBODY; CD45RA ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 14; SYNDECAN 2; SYNDECAN 4; TUMOR NECROSIS FACTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MEMORY T LYMPHOCYTE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHROMATIN; DEOXYRIBONUCLEASE I; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOLOGIC MEMORY; INTRONS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); PROTEIN KINASE INHIBITORS; RNA, MESSENGER; SYNDECAN-2; SYNDECAN-4; UP-REGULATION;

EID: 41849137194     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.01.033     Document Type: Article

References (69)

1. Akbar A.N., Terry L., Timms A., Beverley P.C., and Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J. Immunol. 140 (1988) 2171-2178
2. Alexopoulou A.N., Multhaupt H.A., and Couchman J.R. Syndecans in wound healing, inflammation and vascular biology. Int. J. Biochem. Cell Biol. 39 (2007) 505-528
3. Bass M.D., Roach K.A., Morgan M.R., Mostafavi-Pour Z., Schoen T., Muramatsu T., Mayer U., Ballestrem C., Spatz J.P., and Humphries M.J. Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix. J. Cell Biol. 177 (2007) 527-538
4. Beauvais D.M., Burbach B.J., and Rapraeger A.C. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J. Cell Biol. 167 (2004) 171-181
5. Beiting D.P., Park P.W., and Appleton J.A. Synthesis of syndecan-1 by skeletal muscle cells is an early response to infection with Trichinella spiralis but is not essential for nurse cell development. Infect. Immun. 74 (2006) 1941-1943
6. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., and Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
7. Bischof D., Elsawa S.F., Mantchev G., Yoon J., Michels G.E., Nilson A., Sutor S.L., Platt J.L., Ansell S.M., von Bulow G., and Bram R.J. Selective activation of TACI by syndecan-2. Blood 107 (2006) 3235-3242
8. Bobardt M.D., Saphire A.C., Hung H.C., Yu X., Van der Schueren B., Zhang Z., David G., and Gallay P.A. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 18 (2003) 27-39
9. Brockstedt U., Dobra K., Nurminen M., and Hjerpe A. Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements. Exp. Cell Res. 274 (2002) 235-245
10. Buxade M., Parra J.L., Rousseau S., Shpiro N., Marquez R., Morrice N., Bain J., Espel E., and Proud C.G. The Mnks are novel components in the control of TNFalpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23 (2005) 177-189
11. Charnaux N., Brule S., Hamon M., Chaigneau T., Saffar L., Prost C., Lievre N., and Gattegno L. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/CXCL12. FEBS J. 272 (2005) 1937-1951
12. Chen E., Hermanson S., and Ekker S.C. Syndecan-2 is essential for angiogenic sprouting during zebrafish development. Blood 103 (2004) 1710-1719
13. Chen L., Klass C., and Woods A. Syndecan-2 regulates transforming growth factor-beta signaling. J. Biol. Chem. 279 (2004) 15715-15718
14. Chung J.S., Dougherty I., Cruz Jr. P.D., and Ariizumi K. Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J. Immunol. 179 (2007) 5778-5784
15. Clasper S., Vekemans S., Fiore M., Plebanski M., Wordsworth P., David G., and Jackson D.G. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J. Biol. Chem. 274 (1999) 24113-24123
16. Couchman J.R. Syndecans: proteoglycan regulators of cell-surface microdomains?. Nat. Rev. Mol. Cell Biol. 4 (2003) 926-937
17. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995) 229-233
18. Dodeller F., Skapenko A., Kalden J.R., Lipsky P.E., and Schulze-Koops H. The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells. Eur. J. Immunol. 35 (2005) 3631-3642
19. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7686-7689
20. Echtermeyer F., Streit M., Wilcox-Adelman S., Saoncella S., Denhez F., Detmar M., and Goetinck P. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107 (2001) R9-R14
21. Espel E., García-Sanz J.A., Aubert V., Menoud V., Sperisen P., Fernández N., and Spertini F. Transcriptional and translational control of TNF-α gene expression in human monocytes by major histocompatibility complex class II ligands. Eur. J. Immunol. 26 (1996) 2417-2424
22. Essner J.J., Chen E., and Ekker S.C. Syndecan-2. Int. J. Biochem. Cell Biol. 38 (2006) 152-156
23. Ethell I.M., Irie F., Kalo M.S., Couchman J.R., Pasquale E.B., and Yamaguchi Y. EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 31 (2001) 1001-1013
24. Gilsbach R., Kouta M., Bonisch H., and Bruss M. Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques 40 (2006) 173-177
25. Gotte M. Syndecans in inflammation. FASEB J. 17 (2003) 575-591
26. Granes F., Garcia R., Casaroli-Marano R.P., Castel S., Rocamora N., Reina M., Urena J.M., and Vilaro S. Syndecan-2 induces filopodia by active cdc42Hs. Exp. Cell Res. 248 (1999) 439-456
27. Gribnau J., Diderich K., Pruzina S., Calzolari R., and Fraser P. Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol. Cell 5 (2000) 377-386
28. Grootjans J.J., Zimmermann P., Reekmans G., Smets A., Degeest G., Durr J., and David G. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13683-13688
29. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., Manning A.M., and Firestein G.S. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108 (2001) 73-81
30. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., Qiang F., Gorelik L., Kalled S.L., Acha-Orbea H., Rennert P.D., Tschopp J., and Schneider P. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201 (2005) 1375-1383
31. Iozzo R.V., and San Antonio J.D. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest. 108 (2001) 349-355
32. Ishiguro K., Kadomatsu K., Kojima T., Muramatsu H., Iwase M., Yoshikai Y., Yanada M., Yamamoto K., Matsushita T., Nishimura M., Kusugami K., Saito H., and Muramatsu T. Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J. Biol. Chem. 276 (2001) 47483-47488
33. Jaakkola P., Kontusaari S., Kauppi T., Maata A., and Jalkanen M. Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes. FASEB J. 12 (1998) 959-969
34. Jaakkola P., Maatta A., and Jalkanen M. The activation and composition of FiRE (an FGF-inducible response element) differ in a cell type- and growth factor-specific manner. Oncogene 17 (1998) 1279-1286
35. Jaakkola P., Vihinen T., Maatta A., and Jalkanen M. Activation of an enhancer on the syndecan-1 gene is restricted to fibroblast growth factor family members in mesenchymal cells. Mol. Cell Biol. 17 (1997) 3210-3219
36. Jones K.S., Fugo K., Petrow-Sadowski C., Huang Y., Bertolette D.C., Lisinski I., Cushman S.W., Jacobson S., and Ruscetti F.W. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J. Virol. 80 (2006) 8291-8302
37. + T cells. J. Virol. 79 (2005) 12692-12702
38. Koo B.K., Jung Y.S., Shin J., Han I., Mortier E., Zimmermann P., Whiteford J.R., Couchman J.R., Oh E.S., and Lee W. Structural basis of syndecan-4 phosphorylation as a molecular switch to regulate signaling. J. Mol. Biol. 355 (2006) 651-663
39. Kramer K.L., Barnette J.E., and Yost H.J. PKCgamma regulates syndecan-2 inside-out signaling during xenopus left-right development. Cell 111 (2002) 981-990
40. Kramer K.L., and Yost H.J. Ectodermal syndecan-2 mediates left-right axis formation in migrating mesoderm as a cell-nonautonomous Vg1 cofactor. Dev. Cell 2 (2002) 115-124
41. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14 (1996) 233-258
42. McArthur M., Gerum S., and Stamatoyannopoulos G. Quantification of DNaseI-sensitivity by real-time PCR: quantitative analysis of DNaseI-hypersensitivity of the mouse beta-globin LCR. J. Mol. Biol. 313 (2001) 27-34
43. McFall A.J., and Rapraeger A.C. Identification of an adhesion site within the syndecan-4 extracellular protein domain. J. Biol. Chem. 272 (1997) 12901-12904
44. McFall A.J., and Rapraeger A.C. Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4. J. Biol. Chem. 273 (1998) 28270-28276
45. McQuade K.J., Beauvais D.M., Burbach B.J., and Rapraeger A.C. Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts. J. Cell Sci. 119 (2006) 2445-2456
46. Miller M.R., Castellot Jr. J.J., and Pardee A.B. A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation. Biochemistry 17 (1978) 1073-1080
47. Modrowski D., Basle M., Lomri A., and Marie P.J. Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts. J. Biol. Chem. 275 (2000) 9178-9185
48. Morgan M.R., Humphries M.J., and Bass M.D. Synergistic control of cell adhesion by integrins and syndecans. Nat. Rev. Mol. Cell Biol. 8 (2007) 957-969
49. Nazarenko I., Lowe B., Darfler M., Ikonomi P., Schuster D., and Rashtchian A. Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore. Nucleic Acids Res. 30 (2002) e37
50. Ornitz D.M., Yayon A., Flanagan J.G., Svahn C.M., Levi E., and Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell Biol. 12 (1992) 240-247
51. Parish C.R. The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 6 (2006) 633-643
52. Patel M., Yanagishita M., Roderiquez G., Bou-Habib D.C., Oravecz T., Hascall V.C., and Norcross M.A. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses 9 (1993) 167-174
53. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
54. Picker L.J., Treer J.R., Ferguson-Darnell B., Collins P.A., Buck D., and Terstappen L.W. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor l-selectin on T cells during the virgin to memory cell transition. J. Immunol. 150 (1993) 1105-1121
55. Pursiheimo J.P., Jalkanen M., Tasken K., and Jaakkola P. Involvement of protein kinase A in fibroblast growth factor-2-activated transcription. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 168-173
56. Pursiheimo J.P., Saari J., Jalkanen M., and Salmivirta M. Cooperation of protein kinase A and Ras/ERK signaling pathways is required for AP-1-mediated activation of fibroblast growth factor-inducible response element (FiRE). J. Biol. Chem. 277 (2002) 25344-25355
57. Rapraeger A.C. Molecular interactions of syndecans during development. Semin. Cell Dev. Biol. 12 (2001) 107-116
58. Rautava J., Soukka T., Heikinheimo K., Miettinen P.J., Happonen R.P., and Jaakkola P. Different mechanisms of syndecan-1 activation through a fibroblast-growth-factor-inducible response element (FiRE) in mucosal and cutaneous wounds. J. Dent. Res. 82 (2003) 382-387
59. Saoncella S., Calautti E., Neveu W., and Goetinck P.F. Syndecan-4 regulates ATF-2 transcriptional activity in a Rac1-dependent manner. J. Biol. Chem. 279 (2004) 47172-47176
60. Smith Jr. M.F., Novotny J., Carl V.S., and Comeau L.D. Helicobacter pylori and toll-like receptor agonists induce syndecan-4 expression in an NF-kappaB-dependent manner. Glycobiology 16 (2006) 221-229
61. Vihinen T., Maatta A., Jaakkola P., Auvinen P., and Jalkanen M. Functional characterization of mouse syndecan-1 promoter. J. Biol. Chem. 271 (1996) 12532-12541
62. von Bulow G.U., van Deursen J.M., and Bram R.J. Regulation of the T-independent humoral response by TACI. Immunity 14 (2001) 573-582
63. Whiteford J.R., and Couchman J.R. A conserved NXIP motif is required for cell adhesion properties of the syndecan-4 ectodomain. J. Biol. Chem. 281 (2006) 32156-32163
64. Wrenshall L.E., and Platt J.L. Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J. Immunol. 163 (1999) 3793-3800
65. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., Tumas D., Grewal I.S., and Dixit V.M. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2 (2001) 638-643
66. Yayon A., Klagsbrun M., Esko J.D., Leder P., and Ornitz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64 (1991) 841-848
67. Yoo J., Jeong M.J., Cho H.J., Oh E.S., and Han M.Y. Dynamin II interacts with syndecan-4, a regulator of focal adhesion and stress-fiber formation. Biochem. Biophys. Res. Commun. 328 (2005) 424-431
68. Zhang J., Salojin K.V., Gao J.X., Cameron M.J., Bergerot I., and Delovitch T.L. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J. Immunol. 162 (1999) 3819-3829
69. Zhang Y., Pasparakis M., Kollias G., and Simons M. Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-alpha. J. Biol. Chem. 274 (1999) 14786-14790